CHF82.75
2.29% today
SIX Swiss Exchange, Jun 27, 02:18 pm CET
ISIN
CH0012530207
Symbol
BANB
Sector
Industry

Bachem Holding Share price

CHF80.90
-5.45 6.31% 1M
+16.35 25.33% 6M
+15.90 24.46% YTD
+5.30 7.01% 1Y
-30.70 27.51% 3Y
+55.22 215.03% 5Y
+70.80 700.99% 10Y
SIX Swiss Exchange, Closing price Wed, Jun 26 2024
ISIN
CH0012530207
Symbol
BANB
Sector
Industry

Key figures

Market capitalization CHF6.07b
Enterprise Value CHF5.77b
PER (TTM) P/E ratio 54.20
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 9.99
P/S ratio (TTM) P/S ratio 10.51
P/B ratio (TTM) P/B ratio 4.59
Dividend yield 0.99%
Last dividend (FY23) CHF0.80
Sales growth (TTM) Sales growth 8.57%
Turnover (TTM) Turnover CHF577.32m
EBIT (operating result TTM) EBIT CHF128.56m
Free cash flow (TTM) Free cash flow CHF-13.80m
EPS (TTM) EPS CHF1.49
P/E ratio expected 53.43
P/S ratio expected 9.74
EV/Sales expected 9.26
Show more

Is Bachem Holding a top scorer stock according to the dividend, high growth investing or Leverman strategy?

As a free StocksGuide basic user, you can view the scores for all 6,947 shares worldwide.

Bachem Holding Share analysis

Unlock scores for free

Analyst opinions

5 Analysts have issued a Bachem Holding forecast:

4x Hold
80%
1x Sell
20%

Analyst opinions

5 Analysts have issued a Bachem Holding forecast:

Hold
80%
Sell
20%

Financial data from Bachem Holding

Profit and loss account P&L | Balance sheet | Cash flow


TTM Annually
Dec '23
+/-
%
577 577
9% 9%
100%
- Direct costs 400 400
11% 11%
69%
177 177
3% 3%
31%
- Selling and administrative expenses - -
-
-
- Research and development costs 11 11
53% 53%
2%
166 166
4% 4%
29%
- Depreciation and amortization 37 37
12% 12%
6%
EBIT (operating result) EBIT 129 129
2% 2%
22%
Net profit 112 112
11% 11%
19%

Figures in millions CHF.

Don't miss a thing! We will send you all news about the Bachem Holding share directly to your mailbox free of charge.

If you wish, you can receive an e-mail every morning in time for breakfast containing all the stock news relevant to you.

Company profile

Bachem Holding AG engages in the provision of peptides and oligonucleotides. It operates through the Europe/Asia and North America geographical segments. It offers project management, research grade production, catalog peptides, peptide NCES, and commercial NCES. The company was founded in 2003 and is headquartered in Bubendorf, Switzerland.

Head office Switzerland
CEO Thomas Meier
Employees 2,006
Founded 2003
Website www.bachem.com

Register for free

StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.

The Apple share at a glance with charts, current key figures, news and share analyses.
The best dividend stocks in the dividend top scorer list.
Stock analyses of the best stocks worldwide.
Build wealth now